Attached article mentions Edward's next generation Sapien X4 did a small study (probably EFS) of 23 patients. In this study they had one stroke and 5 permament pacemakers. Not good numbers viz our study of zero strokes and zero permament pacemakers.
https://cardiovascularbusiness.com/topics/clinical/structural-heart-disease/tavr/next-gen-tavr-valve-tested-patients-first-time
Attached article mentions Edward's next generation Sapien X4 did...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.40 |
Change
-0.100(0.49%) |
Mkt cap ! $388.2M | |||
| Open | High | Low | Value | Volume |
| $20.40 | $20.40 | $20.20 | $16.64K | 821 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 167 | $20.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.40 | 375 | 1 |
View Market Depth
| Last trade - 11.18am 14/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |